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diagnosis was associated with an increased age-adjusted risk of all cause death within 1 year of
diagnosis for oesophageal squamous cell carcinoma (RR = 1.99 95% CI 1.24,3.12) but not oesophageal
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Augmenting cancer registry data with
health survey data with no cases in
common: the relationship between prediagnosis health behaviour and postdiagnosis survival in oesophageal cancer
Paul P. Fahey1* , Andrew Page2, Glenn Stone3 and Thomas Astell-Burt4

Abstract
Background: For epidemiological research, cancer registry datasets often need to be augmented with additional
data. Data linkage is not feasible when there are no cases in common between data sets. We present a novel
approach to augmenting cancer registry data by imputing pre-diagnosis health behaviour and estimating its
relationship with post-diagnosis survival time.
Methods: Six measures of pre-diagnosis health behaviours (focussing on tobacco smoking, ‘at risk’ alcohol
consumption, overweight and exercise) were imputed for 28,000 cancer registry data records of US oesophageal
cancers using cold deck imputation from an unrelated health behaviour dataset. Each data point was imputed
twice. This calibration allowed us to estimate the misclassification rate. We applied statistical correction for the
misclassification to estimate the relative risk of dying within 1 year of diagnosis for each of the imputed behaviour
variables. Subgroup analyses were conducted for adenocarcinoma and squamous cell carcinoma separately.
Results: Simulated survival data confirmed that accurate estimates of true relative risks could be retrieved for health
behaviours with greater than 5% prevalence, although confidence intervals were wide. Applied to real datasets, the
estimated relative risks were largely consistent with current knowledge. For example, tobacco smoking status 5
years prior to diagnosis was associated with an increased age-adjusted risk of all cause death within 1 year of
diagnosis for oesophageal squamous cell carcinoma (RR = 1.99 95% CI 1.24,3.12) but not oesophageal
adenocarcinoma RR = 1.61, 95% CI 0.79,2.57).
Conclusions: We have demonstrated a novel imputation-based algorithm for augmenting cancer registry data for
epidemiological research which can be used when there are no cases in common between data sets. The
algorithm allows investigation of research questions which could not be addressed through direct data linkage.
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Background
In 2011 it was estimated that that the cost of maintaining the United States’ National Program of Cancer
Registries was $US60.77 per case [1]. The estimated
number of new United States cancer cases in 1999 was
1,291,451 [2] and 1,762,450 in 2019 [3] an increase of
36% in 20 years. As in any public investment, there is always a need to maintain, and indeed increase, benefits of
cancer registries relative to costs.
The role of cancer registries has changed considerably
over time [4]. Since the 1990s, for example, the development of specialised data linkage infrastructure has open
wide new research applications [4]. However, data linkage may not be feasible in all circumstances. There are
still research questions which are waiting for a suitable
method of analysis.
Oesophageal cancer is the seventh most common cancer by site [5], has low survival [6], and caused an estimated 1 in 20 cancer deaths worldwide in 2018 [5]. It has
been estimated that 71% of male and 59% of female
oesophageal cancer deaths in the US arise from modifiable
health behaviours: including smoking (50%), alcohol consumption (17%) and excess body weight (27%) [7]. The
impact of pre-diagnosis health behaviour on oesophageal
cancer survival is uncertain. As survival times are short,
the carry-over effect of pre-diagnosis behaviour may be
important, and potentially impact treatment choices [8].
Further, as health behaviours in populations change over
time [9, 10], predicting the impact of behaviour on cancer
survival would assist in forecasting future disease burden
and health service requirements.
Associations between oesophageal cancer incidence
and health behaviour (including tobacco smoking, alcohol consumption, body mass index and physical activity)
differ by histological sub-type [11, 12] with oesophageal
squamous cell carcinoma (ESCC) and oesophageal
adenocarcinoma (EAC) usually examined separately.
Similar differences may exist for survival time [13, 14].
Nowadays, cancer survival data is generally available
through cancer registries [15], but not data on prediagnosis health behaviour. Registry data needs to be
augmented with additional data collection or linkage to
external data sources. Additional data collection can be
time consuming, expensive and subject to survivor bias
[16] and data linkage needs the same individuals to be
present and identifiable in both data collections and is
less feasible for rare disease like oesophageal cancer.
When faced with missing data, researchers sometimes
use imputation [17]. Imputing data is likely to lead to
misclassification of health behaviours (such as smokers
classified as non-smokers and vice-versa). However, repeated observations of the same behaviour can be used
to quantify, and subsequently correct for misclassification [18]. In this paper we investigate the possibility that,
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with large datasets and careful calibration, imputing a
completely missing variable could return valid results.
We describe and evaluate an algorithm for assessing the
relationship between pre-diagnosis health behaviours
and survival at one-year post-diagnosis for oesophageal
cancer where survival is derived from cancer registry
data and key health behaviours are fully imputed using
unrelated health survey data.

Methods
Data sources

Oesophageal cancer cases were extracted from the Surveillance, Epidemiology, and End Results Program (SEER)
cancer registries database, which combines data from cancer registries in up to 13 US States covering up to 28% of
the US population [19]. Available data included patient
demographics and outcomes (including survival time).
All records of primary oesophageal cancers diagnosed
between 2006 to 2014 were downloaded using the
SEER*Stat utility [20]. After excluding 112 cases < 35
years of age as atypical, the dataset contained 34,972
oesophageal cancer cases.
Health behaviour data of US residents were extracted
from the Behavioural Risk Factor Surveillance System
(BRFSS) [21]. This telephone survey of the adult population of US residents (all States) has been conducted annually since 1984. All 3,018,830 records from 2001 to
2009 were included.
Given that health behaviour can change after diagnosis
[22, 23] the BRFSS health behaviour best represented
the health behaviour of oesophageal cancer cases prediagnosis. We added a 5-year lag to minimise the risk of
early symptoms influencing behaviour. The initial year
was the earliest year in which BRFSS used a consistent
definition for health behaviours selected for the present
study. The end year was the most recently available
SEER cancer registry data which allowed at least 12months follow-up.
Outcomes, predictors and subgroups

The dichotomous outcome was all-cause mortality
within 1 year of diagnosis.
Six self-reported measures of health behaviour were
selected based on previous associations with oesophageal
cancer [11, 24] and availability in the BRFSS dataset:
 Current tobacco smoking (yes or no), defined as

daily or less than daily smoking;
 Alcohol consumption – possible binge drinking (yes

or no), defined as ≥5 standard drinks for males or ≥
4 standard drinks for females on at least one
occasion in the month prior to survey;
 Alcohol consumption – possible heavy drinking (yes
or no), defined as > 2 standard drinks per day for
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men and > 1 standard drink per day for women in
the month prior to survey;
 Physical activity (yes or no), defined as any physical
activity or exercise in the past 30 days other than for
regular job;
 Obese (yes/no), defined as body mass index ≥30 kg/
m2; and
 Current tobacco smoking with regular alcohol (yes
or no), defined as current tobacco smoking with ≥1
standard drink of alcohol per day on average in the
previous month.
Histological subgroups were defined using International Classification of Diseases for Oncology, third
edition (ICD-O-3) with 805–808 indicating ESCC (n =
10,454) and 814–838 indicating EAC (n = 17,950).

Imputation method and covariates

The complete absence of data on health behaviour
meant that regression-based imputation and multiple
imputation could not be used [25]. Random cold deck
imputation [17] based on demographic strata was appropriate, as there were demographic variables in common
between the two datasets and individuals from the same
demographic group have a greater likelihood of engaging
in similar health behaviours [26].
In random cold deck imputation individuals are allocated into strata according to auxiliary variables and
then, within each stratum, one ‘donor’ record is randomly selected for each ‘recipient’ record. The BRFSS
health behaviour data were the donor records and the
SEER cancer registry data were the recipients. The recipient record is assigned the behaviour of the donor
record. The more, and the more informative, the auxiliary variables the greater the chance the imputed behaviour will be correct.
Six auxiliary variables were used:
– Age category at diagnosis (5-year groups from 3539y to 75-79y then >80y);
– Gender (male; female);
– Marital status (married, including common law;
single or never married; widowed; divorced);
– Race (white; black; Asian or Pacific Islander;
American Indian or Alaska Native);
– State of residence (Alaska; California; Connecticut;
Georgia; Hawaii; Iowa; Kentucky; Louisiana;
Michigan; New Jersey; New Mexico; Utah;
Washington);
– Year of diagnosis (2006 to 2014).
To produce the 5-year lag, we defined the donor records to be BRFSS health behaviour records which were
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5 years earlier and one age-group younger than the corresponding SEER cancer case.
There were 37,440 possible combinations of the auxiliary variable categories, 7397 of which occurred within
the SEER oesophageal cancer cases. Of these, 6986
(94.4%) contained at least one eligible BRFSS donor
record.
To allow calibration, we randomly selected two BRFSS
donor records for each SEER case (without replacement), such that each cancer case had two imputed
values for each lifestyle variable. Where donor records
were exhausted before cancer cases, the cancer case was
omitted from the analysis (see Additional file 1).
Missing data, exclusions and the final dataset

Approximately 80% of the 35,084 eligible oesophageal
cancer cases were included in the analyses. (Additional
file 2). SEER cases were excluded for missing survival
time or auxiliary variables (n = 2784, 8.0%) or failing to
find two donor records (from 4353 to 4453 (12.4 to
12.7%) varying between health behaviours). Cases without two donor records were more likely to be older,
from earlier study years and California residents (Additional file 3).
Only 458,780 of the BRFSS health behaviour records
matched the SEER cases on the auxiliary variables. The
number with missing health behaviour ranged from 564
(0.1%) for physical activity to 17,624 (3.9%) for obesity.
To avoid imputing a missing value into a missing value,
these records were excluded. To avoid cumulative effects, we created six separate donor datasets (each containing complete cases for one of the six health
behaviours) and imputed each health behaviour
independently.
Calibrating the effectiveness of imputation

We used the paired imputed values to calibrate the imputation process (see Additional file 4). In brief, let pi
represent the proportion of imputed values where the
behaviour is present. If the imputation process retained
no information on behaviour, the expected proportion of
behaviour present to behaviour present matches is p2i the agreement arising through chance alone. If the
imputation process is informative, the proportion of behaviour present to behaviour present matches is greater
than chance. We modelled these excess matches as pi(1
− pi) ρ where ρ is a measure of correlation [27].
We estimated pi as the proportion imputed to have
the behaviour (averaged across the two imputed values)
and estimated ρ using the phi coefficient (the correlation
coefficient for dichotomous variables) between the pairs
of imputed values. All analyses were conducted separately for each health behaviour.
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Statistical analysis

Checking the algorithm with simulated data

For each behaviour, we cross-tabulated the first set of
imputed values against 1 year survival status and calculated the relative risk of death within 1 year, RRi. The
subscript i signifies that the imputed data were used in
the calculations.
Other potential predictors of survival times were investigated using log-binary regression with associated log likelihood ratio statistics and area under the receiver operator
curves (Additional file 5). Age was identified as a confounder
as both post-diagnosis survival and proportion recording
each health behaviours were lower among older age groups
(Additional file 5). To adjust for this, age-adjusted relative
risks, adjRRi, were estimated using the Cochrane-MantelHaenzel method [28]. Other potential demographic predictors of survival were found to be of lesser impact or
confounded with age (see Additional file 5).
Beyond the demographic variables, cancer stage at diagnosis (coded by SEER according to the AJCC Cancer Staging Manual 6th Edition [29]) was confirmed as a stronger
predictor of survival (Additional file 5) but, occurring after
health behaviour exposure, may partially lie on the disease
pathway. That is, smokers may have more advanced disease at diagnosis due to their smoking and so correcting
for cancer stage at diagnosis may falsely attenuate the association between pre-diagnosis smoking and survival post
diagnosis [30]. Subgroup analyses for cancer stage at diagnosis are provided in Additional file 8.
Non-differential misclassification errors will, barring
random error and confounding, attenuate the estimated
relative risk toward the null [31]. The mathematical relationship between the relative risk using the imputed
data, RRi, and the true relative risk for the cancer cases,
RRT, is derived in Additional file 6. In brief, if the prevalence of behaviour is the same between the donor records and cancer cases in each stratum, the true relative
risk can be estimated using

In the absence of a cohort showing the true relationship
between pre-diagnosis health behaviour and postdiagnosis survival time, we used simulated data to test
the algorithm.
The first set of imputed behaviour was designated to
be the ‘true’ health behaviour of each cancer case. For
each health behaviour we separately simulated seven
survival status variables (repeated 100 times): to produce
relative risks of 0.50, 0.66, 0.80, 1.00, 1.25, 1.50 and 2.00
while maintaining the overall rate of the health behaviour pi and 1 year death rate (Additional file 7).
The imputed relative risks were obtained using the
second set of imputed health behaviours. As the second
set of imputed values were selected independently and
without replacement, they had a similar relationship
with the first set of simulated data as with the actual
cancer cases. The main difference is that the simulated
survival data, being based only on the behaviour of interest, have no relationship with (confounding from) any
other variables. The true data were likely to display more
complex relationships.

RRT ¼ 1−

ðRRi −1Þ
ðRRi −1Þpi ð 1−ρÞ−ρ

Extreme values of pi and/or ρ can be problematic. For
example, when ρ = 0, RRT is negative: an impossible
value for a relative risk.
Random cold deck imputation was repeated 100 times,
separately for each of the six health behaviours. As
donor records were selected at random within strata,
each statistic varied between repetitions. Results were reported as the median value from the 100 repetitions with
the associated 2.5 and 97.5 percentiles as empirical 95%
confidence intervals. We report subgroup analyses for
ESCC and EAC. Where more than 5% of the estimates
of the true relative risk RRT were impossible, the imputation process was labelled as ‘failed’.

Results
Calibrating the imputation

The estimated proportion of cancer cases with a given
health behaviour, pi, ranged from a median of 0.737 for
physical activity to 0.034 for current smoking with regular drinking (Table 1). The phi coefficients, φ, show that
there is usually a positive correlation between the two
imputed values, albeit weak (medians between 0.008 and
0.077). This confirms that some information about
health behaviour is being conveyed through the random
cold deck imputation. The value npi(1 − pi)ρ, the number
of correct matches greater than would be expected
through chance, quantifies the information conveyed
through the imputation. ‘Heavy drinking’, and ‘current
smoking with regular drinking’, had the lowest prevalence (median of 0.05 or less), the lowest correlations between imputed observations (median less than 0.025)
and hence lowest information (medians below 20
matches beyond chance).
Analyses using simulated survival status

The simulated relative risks of survival were accurate to
two-decimal places and precise (with a maximum margin of error of 0.07) (Table 2). The relative risks obtained by using the (second) imputed behaviour (RRi)
were substantially attenuated toward the null differing
from 1.0 only in the second decimal place.
Estimation of the true relative risk from the imputed
relative risk failed for the two least common health behaviours: ‘heavy drinking’ and ‘current smoking with
regular drinking’. For the other four behaviours, the
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Table 1 The estimated proportions with each health behaviour, the phi coefficient between imputed values and the estimated
excess matches for each analysis
Behaviour
5 years
before
diagnosis

N

Estimated proportion with behaviour, pbi

Estimated phi coefficient, ^
ρ=φ

Estimated excess matches, nb
pi ð1−b
pi Þ^
ρ

Median

95% CI

Median

95% CI

Median

95% CI

Current smoking
overall

27,835

0.159

0.157,0.162

0.071

0.059,0.084

262.2

220.1312.2

ESCC

8914

0.166

0.162,0.170

0.077

0.061,0.097

94.8

74.5120.7

EAC

15,726

0.157

0.153,0.159

0.066

0.052,0.081

137.0

107.4169.5

Overall

27,750

0.100

0.098, 0.102

0.060

0.049,0.077

150.5

121.5192.1

ESCC

8891

0.086

0.082,0.089

0.060

0.042,0.086

42.2

29.8,61.1

EAC

15,673

0.109

0.106,0.111

0.058

0.042,0.079

88.6

63.6120.3

Binge drinking

Heavy drinking
Overall

27,749

0.048

0.047,0.050

0.011

0.002,0.025

14.3

2.7,32.0

ESCC

8888

0.046

0.043,0.049

0.015

−0.002,0.036

5.7

− 0.7,14.2

EAC

15,676

0.050

0.048,0.052

0.008

−0.004,0.028

6.0

−3.0,20.8

Physical activity
Overall

27,830

0.737

0.734,0.740

0.034

0.026,0.046

185.1

139.4247.4

ESCC

8912

0.716

0.709,0.721

0.036

0.016,0.056

64.7

29.6100.2

EAC

15,724

0.750

0.746,0.754

0.031

0.013,0.047

91.4

40.0,138.4

Overall

27,796

0.257

0.254,0.261

0.030

0.020,0.042

160.2

108.4226.8

ESCC

8898

0.262

0.255,0.268

0.045

0.024,0.061

77.0

41.4104.6

EAC

15,709

0.256

0.251,0.261

0.023

0.012,0.041

67.8

35.0,122.4

Obese

Current smoking with regular drinking
Overall

27,735

0.034

0.033,0.035

0.022

0.009,0.038

19.8

8.0,34.2

ESCC

8883

0.031

0.029,0.033

0.024

−0.000,0.049

6.2

−0.0,13.5

EAC

15,670

0.035

0.034,0.037

0.021

0.004,0.042

11.5

2.1,22.4

pbi proportion of imputed values where the health behaviour is present
^ = φ the correlation between the pairs of imputed values (calculated as the phi coefficient)
ρ
ρ= the excess number of correct matches greater than would be expected through chance alone
npbi ð1−pbi Þ^
Median median of 100 repetitions of the imputation algorithm,
95% CI = empirical 95% confidence interval created from the 2.5 and 97.5 percentiles obtained from 100 repetitions of the imputation algorithm,
N number of SEER oesophageal cancer cases receiving data from two donor records from the BRFSS health behaviour datasets
ESCC oesophageal squamous cell carcinoma,
EAC oesophageal adenocarcinoma

median of the estimated true relative risk was accurate
to one, and often two, decimal places. However, the confidence intervals were wide and few excluded no
association.
Analyses using true survival status

When imputing the health behaviours onto SEER cancer
cases, the median imputed relative risks (RRi) are attenuated to close to 1.0 (Table 3). Less expectedly, most of
the median risks are less than 1.0; suggesting that most
behaviours were associated with a lower rate of death
within one year of diagnosis. Many of the age-adjusted

imputed relative risks had the opposite direction of association confirming the potential for confounding by age.
Current tobacco smoking 5 years prior to diagnosis was
detrimental to one-year survival after diagnosis following
adjustment for age, particularly in ESCC where the estimated relative risk was 2.0 (95%CI 1.24, 3.12). For ESCC,
the median relative risk for binge drinking 5 years prior
to diagnosis was 1.52 although the range of possible relative risks was wide (95% CI 0.44,2.75). Similar results
were seen for obesity (ESCC estimated RR 1.73, 95%CI
0.83,4.17). Physical activity 5-years prior to diagnosis
was protective for survival with median estimated
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Table 2 Result of simulation-based testing of whether or not the imputation can be used to predict relative risk
Target RR

Simulated data RR

Imputed RR (RRi)

Impossible Result (RRT < 0)

Estimated true RR (RRT)

Median

95% CI

Median

95% CI

Frequency

Median

95% CIb

0.501

0.475,0.521

0.964

0.934,0.993a

0

0.519

0.163,0.904a

a

Current smoking
RR = 0.5
RR = 0.66

0.660

0.635,0.683

0.973

0.944,0.999

0

0.638

0.300,0.985a

RR = 0.80

0.799

0.771,0.823

0.983

0.952,1.017

0

0.753

0.375,1.226

RR = 1.00

1.001

0.976,1.026

0.997

0.967,1.027

0

0.957

0.577,1.444

RR = 1.25

1.249

1.220,1.287

1.017

0.989,1.048

0

1.254

0.856,1.793

RR = 1.50

1.499

1.465,1.528

1.032

1.005,1.059a

0

1.486

1.069,1.947a

RR = 2.00

2.000

1.974,2.034

1.064

1.034,1.092a

0

2.047

1.542,2.532a

RR = 0.5

0.501

0.474,0.526

0.967

0.940,0.996a

0

0.478

0.087,0.927a

RR = 0.66

0.659

0.624,0.692

0.976

0.945,1.015

1

0.629

0.173,1.316

RR = 0.80

0.798

0.758,0.830

0.988

0.959,1.025

0

0.805

0.341,1.448

RR = 1.00

0.997

0.963,1.033

0.999

0.971,1.032

0

0.981

0.518,1.492

RR = 1.25

1.245

1.213,1.278

1.016

0.984,1.054

0

1.271

0.739,2.029

RR = 1.50

1.499

1.463,1.534

1.030

0.990,1.068

0

1.517

0.831,2.246

Binge drinking

1.999

1.978,2.028

1.058

1.021,1.093

0

2.014

1.352,2.717a

RR = 0.5

0.500

0.450,0.548

0.995

0.945,1.046

40

failed

failed

RR = 0.66

0.661

0.606,0.697

0.995

0.946,1.046

34

failed

failed

RR = 0.80

0.799

0.746,0.847

0.997

0.944,1.053

43

failed

failed

RR = 1.00

0.997

0.949,1.045

0.998

0.940,1.041

32

failed

failed

RR = 1.25

1.251

1.210,1.300

1.003

0.959,1.053

22

failed

failed

RR = 1.50

1.497

1.459,1.535

1.012

0.956,1.059

24

failed

failed

RR = 2.00

Not possible

Not possible

RR = 0.5

0.500

0.491,0.509

0.974

0.951,0.997a

0

0.504

0.319,0.901a

RR = 0.66

0.659

0.645,0.671

0.983

0.959,1.006

0

0.632

0.367,1.231

RR = 0.80

0.800

0.782,0.818

0.993

0.971,1.017

0

0.833

0.449,1.907

RR = 1.00

1.002

0.976,1.022

1.001

0.978,1.021

0

1.025

0.488,2.092

RR = 1.25

1.250

1.219,1.276

1.006

0.977,1.030

0

1.206

0.541,2.961

RR = 1.50

1.499

1.455,1.549

1.013

0.987,1.037

2

1.514

0.722,4.078

RR = 2.00

2.003

1.939,2.083

1.021

1.002,1.047*

3

2.127

1.055,10.987a

RR = 0.5

0.499

0.485,0.517

0.983

0.960,1.008

1

0.550

0.028,1.322

RR = 0.66

0.660

0.634,0.680

0.989

0.962,1.016

2

0.665

0.114,1.772

RR = 0.80

0.802

0.777,0.823

0.995

0.967,1.015

1

0.846

0.316,1.676

RR = 1.00

1.002

0.981,1.024

0.999

0.980,1.024

0

0.962

0.461,2.067

RR = 1.25

1.250

1.222,1.274

1.009

0.989,1.030

0

1.335

0.601,2.300

RR = 1.50

1.500

1.468,1.534

1.014

0.987,1.039

0

1.440

0.606,2.796

RR = 2.00

2.002

1.961,2.041

1.025

0.997,1.044

0

1.995

0.886,3.234

RR = 2.00

a

Heavy Drinking

Physical activity

Obese

Current smoking with regular drinking
RR = 0.5

0.504

0.441,0.550

0.988

0.931,1.034

37

failed

failed

RR = 0.66

0.660

0.600,0.713

0.997

0.932,1.066

31

failed

failed
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Table 2 Result of simulation-based testing of whether or not the imputation can be used to predict relative risk (Continued)
Target RR

Simulated data RR

Imputed RR (RRi)

Impossible Result (RRT < 0)

Estimated true RR (RRT)

Median

95% CI

Median

95% CI

Frequency

Median

95% CIb

RR = 0.80

0.797

0.744,0.863

0.991

0.928,1.052

34

failed

failed

RR = 1.00

0.996

0.943,1.049

1.001

0.940,1.059

25

failed

failed

RR = 1.25

1.250

1.183,1.298

1.009

0.954,1.059

16

failed

failed

RR = 1.50

1.497

1.454,1.545

1.000

0.958,1.065

19

failed

failed

RR = 2.00

Not possible

Not possible

Target RR – the relative risk we attempted to achieve in the simulated data
Simulated data RR – the relative risk which was actually achieved between the first imputed value and the simulated one-year survival status
Imputed RR (RRi) – the relative risk calculated using the second imputed data point as the imputed behaviour
Impossible result – instances where the estimated true relative risk was impossible (a negative value)
^
Estimated True RR (RRT) – the estimated true relative risk derived from the imputed relative risk and calibration parameters pbi and ρ
Median median of 100 repetitions of the imputation algorithm,
95% CI = empirical 95% confidence interval created from the 2.5 and 97.5 percentiles obtained from 100 repetitions of the imputation algorithm,
a
95% confidence intervals exclude no association (i.e. exclude relative risk equals 1)
b
excludes impossible result

relative risks of approximately 0.50 (95%CI 0.31, 1.03)
for oesophageal cancer overall.
Estimates of the relative risks could not be retrieved
for the less common behaviours ‘heavy drinking’ and
‘current smoking with regular drinking’. The one relative
risk which was retrieved - a median RR of 3.35 for
current smoking with regular drinking in all oesophageal
cancer - was accompanied by wide uncertainty (95% CI
0.77,11.84).
Subgroup analyses on cancer stage at diagnosis
(Additional file 8), suggests that pre-diagnosis health
behaviours have stronger relationships with one-year
survival in those who are not metastatic at diagnosis.

Discussion
This study shows that an entirely missing variable can
be imputed and return accurate estimates of relative
risks. Nearly all correlation coefficients were positive, indicating that the imputation conveyed some information
about health behaviour, although confidence intervals
were wide. However, for the less common behaviours
(heavy drinking and current smoking with regular drinking), no interpretable information could be retrieved.
The choice of health behaviour variables was restricted to measures available through the BRFSS
health survey. However, the results are consistent
with the literature. We found that tobacco smoking 5
years prior to diagnosis was associated with increased
risk of death 1 year after diagnosis in ESCC (RR =
1.99, 95% CI 1.24,3.12) and, with less certainty, EAC
(RR = 1.61, 95% CI 0.79,2.57). Recent meta analyses
estimated hazard ratios (HRs) of 1.41 (95% CI 1.22,
1.64) and 1.41 (95% CI 0.96,2.09) for current smoking
relative to never smoked in mainly ESCC populations
[32, 33] and 1.19 (95% CI 1.04,1.36) for ever smoking
compared to never smoked in ESCC [24] with no

evidence of association between smoking and survival
in EAC [24, 33]. The unadjusted protective effects of
smoking has also been reported [34, 35] as has the
change in the direction of the association following
age adjustment [35].
A previous meta-analysis found that ever drinking
alcohol had a detrimental association with survival in
ESCC (HR 1.36, 95% CI 1.15, 1.61) but not in EAC
(HR = 1.08 95% CI 0.85, 1.37) [24]. More recent results from China (HR = 1.58, 95% CI 1.21,2.07 [36,
37], HR = 1.45 95% CI 1.13,1.87 [37]) and Japan
(HR = 2.37 95% CI 1.24,4.53 [38]) also support the
detrimental impact of pre-diagnosis alcohol consumption on survival in ESCC. We could not estimate the association between heavy drinking and
survival. However, for binge drinking five years prior
to diagnosis, the median relative risk was 1.52 in
ESCC, although the confidence interval (95% CI 0.44,
2.75) allows no association.
Previous studies have reported that pre-diagnosis
smoking with regular alcohol consumption produced a
disproportionately high risk to post-diagnosis survival in
ESCC (HR 3.84, 95% CI 2.02,7.32 [13]). We observed a
similar association (RR = 3.25, 95% CI 0.77,11.84) with
wider confidence intervals.
In relation to obesity, a recent North American study
[39] found self-reported obesity was associated with
lower survival times in EAC compared to normal weight
(HR 1.77, 95% CI 1.25, 2.51) and a 27 year follow-up of
29,446 participants in China [40] found higher body
mass index protective of death from ESCC (HR = 0.97
per unit increase, 95% CI 0.95,0.99). We found, in contrast, that obesity 5 years pre-diagnosis may be detrimental to one-year post diagnosis survival for ESCC
(median RR = 1.73) although confidence intervals were
wide (95% CI 0.83,4.17).
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Table 3 Estimated relative risks of 1-year survival derived from imputed pre-diagnosis behaviours for SEER oesophageal cancer
cases, 2006–2014; unadjusted and age adjusted
Imputed RR (RRi)

Impossible Result
(RRi < 0)

Estimated True RR
(RRT)

Age-adjusted
Imputed RR
(adjRRi)

Impossible Result
(adjRRi < 0)

Age-adjusted
Estimated True RR
(adjRRT)

Median 95% CI

Frequency

Median 95% CI

Median 95% CI

Frequency

Median 95% CI

Current smoking
All

0.986

0.954,1.009 0

0.806

0.380,1.130

1.051

1.014,
1.078

0

1.794

1.215,2.357a

1.025

0.981,1.067 0

1.349

0.733,2.142

1.064

1.016,
1.111

0

1.990

1.240,3.117

0.959

0.914,1.000 5

0.478

0.039,1.003

1.038

0.985,
1.085

0

1.613

0.785,2.571

0.933

0.900,0.964 49

failed

failed

0.997

0.961,
1.032

1

0.951

0.445,1.539

0.998

0.936,1.059 4

0.991

0.167,1.995

1.033

0.968,
1.101

0

1.515

0.440,2.754

0.863,0.961 72

failed

failed

0.989

0.935,
1.046

3

0.818

0.181,1.890

0.981

0.932,1.028 61

failed

failed

1.010

0.963,
1.060

23

failed

failed

0.995

0.912,1.066 48

failed

failed

1.012

0.929,
1.088

36

failed

failed

0.974

0.907,1.039 66

failed

failed

1.011

0.938,
1.077

35

failed

failed

0.934,0.978 0

0.319

0.165,0.564

0.974

0.956,
1.001

0

0.507

0.307,1.030

0.959

0.925,0.991 2

0.345

0.073,0.811

0.971

0.933,
1.003

1

0.452

0.102,1.071b

0.957

0.929,0.986 1

0.311

0.109,0.675

0.984

0.954,
1.013

0

0.627

0.285,2.180

0.946,0.993 24

failed

failed

1.008

0.983,
1.036

0

1.262

0.559,2.931

0.968,1.039 0

1.004

0.134,2.378

1.027

0.992,
1.068

0

1.733

0.834,4.167

0.917,0.987 76

failed

failed

0.996

0.960,
1.035

8

failed

failed

ESCC
EAC

a

b

a

Binge drinking
All

ESCC
EAC

0.914

a

b

b

b

Heavy drinking
All

ESCC
EAC

Physical activity
All

0.954

a

ESCC
EAC

a

a

a,b

a,b

Obese
All

0.969
1.000

a

ESCC
EAC

0.949

a

Current smoking with regular drinking
All

0.987

0.930,1.058 40

failed

failed

1.044

0.986,
1.120

2

3.254

0.771,11.843

1.044

0.946,1.146 12

failed

failed

1.076

0.973,
1.180

11

failed

failed

0.963

0.861,1.052 60

failed

failed

1.032

0.919,
1.123

13

failed

failed

ESCC
EAC

Imputed RR (RRi) – the relative risk calculated using the imputed behaviour
Impossible result – instances where the estimated true relative risk was impossible (a negative value)
^
Estimated True RR (RRT) – the estimated true relative risk derived from the imputed relative risk and calibration parameters pbi and ρ
Median median of 100 repetitions of the imputation algorithm,
95% CI = empirical 95% confidence interval created from the 2.5 and 97.5 percentiles obtained from 100 repetitions of the imputation algorithm,
a
95% confidence intervals exclude no association (i.e. exclude relative risk equals 1)
b
excludes impossible result

b
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One benefit of the algorithm is that it does not add
any additional information about individuals to the cancer registry data and so, unlike direct data linkage, does
not exacerbate the issues of confidentiality and data security. (The imputed behaviours are only slightly more
likely to be correct than an uninformed guess.) The algorithm also provides protection against biases. Data were
obtained from the SEER cancer registries which are censuses with good population coverage. Many sampling
and non-response biases in the BRFSS health behaviour
data [41] are eliminated when using a census as the reference. However, we used rigid matching criteria and
failed to match 20% of cases. Further investigation of the
trade-off between exact matching and biases arising
from failure to match is required.
As with direct data linkage, our investigations were limited to available health behaviour measures, rather than all
clinically important risk factors. Potentially important
health behaviours such as diet [11, 42] and hot beverages
[42] were unavailable. The number and variety of auxiliary
variables available for matching donor to recipient records
was also limited. Our only investigation of clustering in
health behaviours [43] was for the combination of current
smoking and regular alcohol consumption.
The results display considerable uncertainty with few
instances where the empirical confidence intervals excluded the null. The width of the confidence intervals is
sensitive to n, pi and ρ. Larger n can be achieved by
looking at more common cancers, and/or combining
data from more cancer registries and/or more years. The
proportion with the health behaviour, pi, can be adjusted
through inclusion and exclusion criteria (but will impact
on n). Larger ρ requires more informative auxiliary variables for the imputation.
We do not have access to any true gold standard for
validity testing. A gold standard would be an
oesophageal cancer dataset where behaviour was measured 5 years prior to diagnosis.

Conclusion
In this paper we have demonstrated a novel imputationbased algorithm for augmenting cancer registry data for
epidemiological research and established its face-validity.
The algorithm adds information obtained from an external data set with (presumed) no cases in common, to the
cancer registry data via demographic variables in common. The algorithm is subject to much higher random
error than direct data linkage (depending on how informative the demographic variables are), and requires larger
sample sizes to compensate. However, it does avoid the
aggravation of confidentiality issues (and associated data
security costs) arising from direct data linkage.
We believe this algorithm is likely to allow, at least
preliminary, investigations of a range of research
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questions which cannot be addressed through direct data
linkage; due to insufficient individuals in common, insufficient matching variables and/or costs associated with
data confidentiality and security. By increasing the range
of research question which can be addressed with cancer
registry data, the algorithm further augments the benefits of cancer registries.

Supplementary information
Supplementary information accompanies this paper at https://doi.org/10.
1186/s12885-020-06990-3.
Additional file 1. Provides a conceptual map of the steps in the
imputation process.
Additional file 2. Charts the inclusion and exclusion of data records
from both data sources.
Additional file 3. Shows the proportions of eligible SEER cancer cases
that were unable to be matched with two donor records with nonmissing smoking status.
Additional file 4. Details the mathematical model used to quantify the
agreement between the pairs or imputed values assigned to each cancer
case.
Additional file 5. Shows the strength of associations between
candidate confounding variables and one-year survival. Shows why age
group is an important potential confounder as both the proportion surviving and proportion with the health behaviour present decrease in
older age groups.
Additional file 6. Shows the derivation of the mathematical relationship
between the imputed relative risk and the true relative risk and thus
introduces the formula used to correct for misclassification errors within
the imputed health behaviours.
Additional file 7. Describes how health behaviour and survival status
were assigned to cancer cases so as to produce the target relative risk in
the simulated data sets.
Additional file 8. Tabulates the results of sub-group analyses on cancer
stage I, II and III combined and for cancer stage IV.
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